Home › Amyotrophic Lateral Sclerosis › NCT05116943
Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria - Patient with ALS, ALS-FTD or Similar Neurodegenerative Disease: * Clinical diagnosis of possible, laboratory-supported probable, probable or definite ALS according to modified eL Escorial criteria, suspected ALS according to original el Escorial criteria, or diagnosis of a similar neurodegenerative disorder. * Willing to provide consent, or assent, if physically unable to consent owing to disease-related muscle weakness. Inclusion Criteria - Spouse/Domestic Partner of Patients with ALS/ALS-FTD and Similar Neurodegenerative Disorder or Subject with Family History of ALS, ALS-FTD or Similar Neurodegenerative Disease: * No personal history of ALS, ALS-FTD or other motor neuron disease. * Subjects with family history of ALS, ALS-FTD the affected family member needs to be a first, second, or third degree blood relative. * Willing to provide consent. Exclusion Criteria - Subject with ALS/ALS-FTD or Similar Neurodegenerative Disease: * History of medical disorder that leaves in question whether neurological signs and symptoms potentially related to a neurodegenerative disease may be caused by another unrelated disorder. * Limited mental capacity rendering the subject unable to comply with lumbar puncture or standard phlebotomy procedures. * For lumbar puncture, an increased risk of bleeding complications or allergy to local anesthetic administered or skin antiseptic used for lumbar puncture. Exclusion Criteria - Spouse/Domestic Partner of Patients with ALS/ALS-FTD and Similar Neurodegenerative Disorder or Subject with Family History of ALS, ALS-FTD or Similar Neurodegenerative Disease: * Limited mental capacity rendering the subject unable to comply with lumbar puncture or standard phlebotomy procedures. * For lumbar puncture, an increased risk of bleeding complications or allergy to local anesthetic administered or skin antiseptic used for lumbar puncture.
About the study
The purpose of this study is to collect CSF and blood samples that can be used in future research studies to identify potential biomarkers in blood and cerebrospinal fluid (CSF) collected in Amyotrophic Lateral Sclerosis (ALS) patients.
Sponsor: Mayo Clinic · Participants: 100 · Started: Aug 19, 2013
Contact the study team
Official record on ClinicalTrials.gov — NCT05116943
Locations in the U.S.
| Florida | Mayo Clinic in Florida, Jacksonville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.